Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 112 articles:
HTML format
Text format



Single Articles


    December 2018
  1. SAVIOLI L, Daumerie D
    WHO leadership is essential for the elimination of NTDs.
    Lancet. 2018;390:2765.
    PubMed     Text format    


  2. YAQUB F
    2017: a year in review.
    Lancet. 2018;390:2753-2754.
    PubMed     Text format    


  3. THE LANCET
    Our responsibility to protect the Rohingya.
    Lancet. 2018;390:2740.
    PubMed     Text format    


    July 2018
  4. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
    PubMed     Text format     Abstract available


  5. NATHAVITHARANA RR, Pai M
    New strategies for inpatients with HIV and tuberculosis.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
    PubMed     Text format    


    May 2018
  6. COUSINS S
    Managing MDR tuberculosis in Nepal.
    Lancet. 2018;391:1760-1761.
    PubMed     Text format    


    March 2018
  7. SHARMA D
    Commitments to an end to tuberculosis renewed in India.
    Lancet. 2018;391:1138.
    PubMed     Text format    


  8. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
    The Lancet Commission on tuberculosis: building a tuberculosis-free world.
    Lancet. 2018;391:1132-1133.
    PubMed     Text format    


  9. WINGFIELD T, Tovar MA, Datta S, Saunders MJ, et al
    Addressing social determinants to end tuberculosis.
    Lancet. 2018;391:1129-1132.
    PubMed     Text format    


  10. DAVIES R
    Leo Martinez: striving to end childhood tuberculosis.
    Lancet. 2018 Mar 21. pii: S0140-6736(18)30680.
    PubMed     Text format    


    February 2018
  11. BURKI T
    End of a cholera epidemic in South Sudan declared.
    Lancet. 2018;391:647.
    PubMed     Text format    


  12. MUHSEN K, Green MS, Soskolne V, Neumark Y, et al
    Inequalities in non-communicable diseases in Israel - Authors' reply.
    Lancet. 2018;391:537.
    PubMed     Text format    


  13. WATTS N, Amann M, Ayeb-Karlsson S, Belesova K, et al
    The Lancet Countdown on health and climate change: from 25 years of inaction to a global transformation for public health.
    Lancet. 2018;391:581-630.
    PubMed     Text format    


  14. HONIGSBAUM M
    Superbugs and us.
    Lancet. 2018;391:420.
    PubMed     Text format    


    January 2018
  15. ZAROCOSTAS J
    Mega-crisis in DR Congo.
    Lancet. 2018;391:297-298.
    PubMed     Text format    


  16. THE LANCET
    A new vaccine for typhoid control.
    Lancet. 2018;391:96.
    PubMed     Text format    


  17. THE LANCET
    Tuberculosis: criteria for global leadership?
    Lancet. 2018;391:2.
    PubMed     Text format    


    December 2017
  18. HOLLAND TL, Fowler VG Jr
    Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)33294.
    PubMed     Text format    


  19. THWAITES GE, Scarborough M, Szubert A, Nsutebu E, et al
    Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Dec 14. pii: S0140-6736(17)32456.
    PubMed     Text format     Abstract available


    September 2017
  20. POKROVSKY V
    Tuberculosis and HIV/AIDS: the alien and the predator.
    Lancet. 2017;390:1618-1619.
    PubMed     Text format    


  21. COX H, Reuter A, Furin J, Seddon J, et al
    Prevention of hearing loss in patients with multidrug-resistant tuberculosis.
    Lancet. 2017;390:934.
    PubMed     Text format    


    July 2017
  22. YACOUB M, Mayosi B, ElGuindy A, Carpentier A, et al
    Eliminating acute rheumatic fever and rheumatic heart disease.
    Lancet. 2017;390:212-213.
    PubMed     Text format    


    June 2017
  23. VENKATESH P
    Tuberculosis in India: health policy alone is not enough.
    Lancet. 2017;389:2471.
    PubMed     Text format    


  24. PAI M, Jha P
    Tuberculosis in India: health policy alone is not enough - Authors' reply.
    Lancet. 2017;389:2471-2472.
    PubMed     Text format    


  25. ZAROCOSTAS J
    Cholera outbreak in Haiti-from 2010 to today.
    Lancet. 2017;389:2274-2275.
    PubMed     Text format    


  26. SHARMA DC
    Cyclone Mora devastates south Asia.
    Lancet. 2017;389:2273.
    PubMed     Text format    


  27. ALONSO P, Engels D, Reeder J
    Renewed push to strengthen vector control globally.
    Lancet. 2017;389:2270-2271.
    PubMed     Text format    


    April 2017
  28. MCGILL F, Solomon T
    Acute bacterial meningitis in adults - Authors' reply.
    Lancet. 2017;389:1610.
    PubMed     Text format    


  29. PHAN AD, Benchetrit L, Jacobs FM
    Acute bacterial meningitis in adults.
    Lancet. 2017;389:1609-1610.
    PubMed     Text format    


    March 2017
  30. SHARMA DC
    New plan to end tuberculosis in south and southeast Asia.
    Lancet. 2017;389:1183.
    PubMed     Text format    


  31. ADAM BU, Cosford P, Anderson SR, Abubakar I, et al
    Sustaining tuberculosis decline in the UK.
    Lancet. 2017;389:1176-1177.
    PubMed     Text format    


  32. PAI M, Correa N, Mistry N, Jha P, et al
    Reducing global tuberculosis deaths-time for India to step up.
    Lancet. 2017;389:1174-1176.
    PubMed     Text format    


    February 2017
  33. SHARMA DC
    India plans to expand access to new tuberculosis drug.
    Lancet. 2017;389:685.
    PubMed     Text format    


  34. COUSINS S
    Myanmar grapples with its high tuberculosis burden.
    Lancet. 2017;389:491-492.
    PubMed     Text format    


    January 2017
  35. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    PubMed     Text format     Abstract available


  36. VICTORA CG, Castro MC, Franca GV, Schuler-Faccini L, et al
    Zika rash and increased risk of congenital brain abnormalities - Authors' reply.
    Lancet. 2017;389:152.
    PubMed     Text format    


  37. VOUGA M, Musso D, Schaub B, Panchaud A, et al
    Zika virus: are we going too far?
    Lancet. 2017;389:151.
    PubMed     Text format    


  38. GERARDIN P, Cao-Lormeau VM, Musso D, Despres P, et al
    Zika rash and increased risk of congenital brain abnormalities.
    Lancet. 2017;389:151-152.
    PubMed     Text format    


    December 2016
  39. KODATI S, Palmore TN, Spellman FA, Cunningham D, et al
    Bilateral posterior uveitis associated with Zika virus infection.
    Lancet. 2016 Dec 7. pii: S0140-6736(16)32518.
    PubMed     Text format    


    November 2016
  40. CARRUTH L, Roess AA, Mekonnen YT, Melaku SK, et al
    Zoonotic tuberculosis in Africa: challenges and ways forward.
    Lancet. 2016;388:2460-2461.
    PubMed     Text format    


  41. GOMEZ-DANTES H, Fullman N, Lamadrid-Figueroa H, Cahuana-Hurtado L, et al
    Dissonant health transition in the states of Mexico, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Lancet. 2016;388:2386-2402.
    PubMed     Text format     Abstract available


  42. BERRY C, Achar J, du Cros P
    WHO recommendations for multidrug-resistant tuberculosis.
    Lancet. 2016;388:2234.
    PubMed     Text format    


  43. SOTGIU G, Tiberi S, D'Ambrosio L, Centis R, et al
    WHO recommendations for multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2016;388:2234-2235.
    PubMed     Text format    


  44. ZAK D, Scriba TJ, Hatherill M, Penn-Nicholson A, et al
    Predicting tuberculosis risk - Authors' reply.
    Lancet. 2016;388:2233-2234.
    PubMed     Text format    


  45. KIK SV, Cobelens F, Moore D
    Predicting tuberculosis risk.
    Lancet. 2016;388:2233.
    PubMed     Text format    


  46. GEORGE J
    Antibiotic-impregnated catheters for prevention of bloodstream infection.
    Lancet. 2016;388:2235.
    PubMed     Text format    


  47. GILBERT RE, Mok Q, Millar M, Blundell M, et al
    Antibiotic-impregnated catheters for prevention of bloodstream infection - Authors' reply.
    Lancet. 2016;388:2235-2236.
    PubMed     Text format    


    October 2016
  48. MEGRAUD F, Gisbert JP
    Towards effective empirical treatment for Helicobacter pylori eradication.
    Lancet. 2016 Oct 18. pii: S0140-6736(16)31657.
    PubMed     Text format    


  49. LIOU JM, Fang YJ, Chen CC, Bair MJ, et al
    Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Lancet. 2016 Oct 18. pii: S0140-6736(16)31409.
    PubMed     Text format     Abstract available


  50. RADIN JM, Topol EJ, Andersen KG, Steinhubl SR, et al
    A laboratory in your pocket.
    Lancet. 2016;388:1875.
    PubMed     Text format    


  51. NADDA JP, Singh PK
    New evidence of the tuberculosis burden in Asia demands national action.
    Lancet. 2016 Oct 14. pii: S0140-6736(16)31853.
    PubMed     Text format    


  52. ALDRIDGE RW, Zenner D, White PJ, Williamson EJ, et al
    Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.
    Lancet. 2016 Oct 10. pii: S0140-6736(16)31008.
    PubMed     Text format     Abstract available



  53. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1725-1774.
    PubMed     Text format     Abstract available



  54. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1459-1544.
    PubMed     Text format     Abstract available


  55. REINL J
    UN declaration on antimicrobial resistance lacks targets.
    Lancet. 2016;388:1365.
    PubMed     Text format    


  56. TAM CC, Khan MS, Legido-Quigley H
    Where economics and epidemics collide: migrant workers and emerging infections.
    Lancet. 2016;388:1374-1376.
    PubMed     Text format    


  57. CHEN S, Zhang H, Qu Y, Wu Y, et al
    Occupational challenges of physicians involved in tuberculosis control in China: a qualitative study.
    Lancet. 2016;388 Suppl 1:S88.
    PubMed     Text format     Abstract available


  58. GAO L, Bai L, Liu J, Lu W, et al
    Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study.
    Lancet. 2016;388 Suppl 1:S16.
    PubMed     Text format     Abstract available


    September 2016
  59. LIU J, Platts-Mills JA, Juma J, Kabir F, et al
    Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study.
    Lancet. 2016;388:1291-301.
    PubMed     Text format     Abstract available


  60. BARNETT R
    Infective endocarditis.
    Lancet. 2016;388:1148.
    PubMed     Text format    


  61. AKANMORI BD, Mukanga DO, Mihigo R, Ward M, et al
    New development of medicines for priority diseases in Africa.
    Lancet. 2016;388:1053-4.
    PubMed     Text format    


  62. THE LANCET
    Zika's emerging threat for the Asia-Pacific region.
    Lancet. 2016;388:1026.
    PubMed     Text format    


  63. CHO SY, Kang JM, Ha YE, Park GE, et al
    MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study.
    Lancet. 2016;388:994-1001.
    PubMed     Text format     Abstract available


    August 2016
  64. SLADE E, Dale A, Mahtani K
    Probiotics in very preterm infants: the PiPS trial.
    Lancet. 2016;388:656.
    PubMed     Text format    


  65. DESHPANDE G, Rao S, Athalye-Jape G, Conway P, et al
    Probiotics in very preterm infants: the PiPS trial.
    Lancet. 2016;388:655.
    PubMed     Text format    


  66. MCKINLAY CJ, Rebello C, Tarnow-Mordi W
    Probiotics in very preterm infants: the PiPS trial.
    Lancet. 2016;388:655.
    PubMed     Text format    


  67. BURKI T
    Health crisis intensifying in Nigeria's Borno State.
    Lancet. 2016;388:645.
    PubMed     Text format    


  68. METCALF CJ, Farrar J, Cutts FT, Basta NE, et al
    Use of serological surveys to generate key insights into the changing global landscape of infectious disease.
    Lancet. 2016;388:728-30.
    PubMed     Text format    


  69. HUMBLE AG, Sample CB
    Morgagni's hernia in a hypoxaemic adult.
    Lancet. 2016;388:705.
    PubMed     Text format    


    July 2016
  70. HONIGSBAUM M
    Legionnaires' disease: revisiting the puzzle of the century.
    Lancet. 2016;388:456-7.
    PubMed     Text format    


  71. MILLAR M, Mok Q, Harron K, Gilbert R, et al
    Preventing bloodstream infection in children: What's the CATCH? - Authors' reply.
    Lancet. 2016;388:463.
    PubMed     Text format    


  72. BOYD SE, Rawson TM, Moore LS, Holmes AH, et al
    Preventing bloodstream infection in children: What's the CATCH?
    Lancet. 2016;388:462-3.
    PubMed     Text format    


  73. KIENY MP, Rottingen JA, Farrar J
    The need for global R&D coordination for infectious diseases with epidemic potential.
    Lancet. 2016;388:460-1.
    PubMed     Text format    


  74. MAURICE J
    The Zika virus public health emergency: 6 months on.
    Lancet. 2016;388:449-50.
    PubMed     Text format    


  75. THE LANCET
    Halting the Olympics-Zika virus bandwagon.
    Lancet. 2016;388:437.
    PubMed     Text format    


  76. FEDER HM JR, Rigos L, Teti K
    Pott's disease in a Connecticut toddler.
    Lancet. 2016;388:504.
    PubMed     Text format    


  77. O'FARRELL N
    Control of gonorrhoea and chlamydia in the UK.
    Lancet. 2016;388:342.
    PubMed     Text format    


  78. CAHILL TJ, Prendergast BD
    Haemodialysis is a major risk factor for infective endocarditis - Authors' reply.
    Lancet. 2016;388:340.
    PubMed     Text format    


  79. LABRIOLA L, Jadoul M
    Haemodialysis is a major risk factor for infective endocarditis.
    Lancet. 2016;388:339-40.
    PubMed     Text format    


  80. MATONO T, Kato Y, Yotsu R, Ohmagari N, et al
    Duplicate publication.
    Lancet. 2016;388:238.
    PubMed     Text format    


  81. LAXMINARAYAN R, Amabile-Cuevas CF, Cars O, Evans T, et al
    UN High-Level Meeting on antimicrobials--what do we need?
    Lancet. 2016;388:218-20.
    PubMed     Text format    


  82. KAMARULZAMAN A, Reid SE, Schwitters A, Wiessing L, et al
    Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30769.
    PubMed     Text format     Abstract available


  83. ALTICE FL, Azbel L, Stone J, Brooks-Pollock E, et al
    The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30856.
    PubMed     Text format     Abstract available


  84. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    PubMed     Text format     Abstract available


  85. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    PubMed     Text format     Abstract available


  86. TELISINGHE L, Charalambous S, Topp SM, Herce ME, et al
    HIV and tuberculosis in prisons in sub-Saharan Africa.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30578.
    PubMed     Text format     Abstract available


  87. COUSINS S
    Tackling rheumatic heart disease in Indigenous Australians.
    Lancet. 2016;388:e1.
    PubMed     Text format    


  88. LAZARUS C, Guichard M, Philippe JM, Paux T, et al
    The French experience of the threat posed by Zika virus.
    Lancet. 2016;388:9-11.
    PubMed     Text format    


  89. DUA KS, Hogan WJ, Aadam AA, Gasparri M, et al
    In-vivo oesophageal regeneration in a human being by use of a non-biological scaffold and extracellular matrix.
    Lancet. 2016;388:55-61.
    PubMed     Text format     Abstract available


  90. BIRCHALL M, De Coppi P
    Novel approach to in-vivo oesophageal regeneration.
    Lancet. 2016;388:6-7.
    PubMed     Text format    


    June 2016
  91. ROBERTS DJ, Frosch MP
    Zika and histopathology in first trimester infections.
    Lancet. 2016 Jun 29. pii: S0140-6736(16)30930.
    PubMed     Text format    


  92. HEUKELBACH J, Werneck GL
    Surveillance of Zika virus infection and microcephaly in Brazil.
    Lancet. 2016 Jun 29. pii: S0140-6736(16)30931.
    PubMed     Text format    


  93. FRANCA GV, Schuler-Faccini L, Oliveira WK, Henriques CM, et al
    Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation.
    Lancet. 2016 Jun 29. pii: S0140-6736(16)30902.
    PubMed     Text format     Abstract available


  94. MARTINES RB, Bhatnagar J, de Oliveira Ramos AM, Davi HP, et al
    Pathology of congenital Zika syndrome in Brazil: a case series.
    Lancet. 2016 Jun 29. pii: S0140-6736(16)30883.
    PubMed     Text format     Abstract available


  95. DONALD PR, Van Toorn R
    Use of corticosteroids in tuberculous meningitis.
    Lancet. 2016;387:2585-7.
    PubMed     Text format    


  96. SOTGIU G, Tiberi S, D'Ambrosio L, Centis R, et al
    WHO recommendations on shorter treatment of multidrug-resistant tuberculosis.
    Lancet. 2016;387:2486-7.
    PubMed     Text format    



  97. Dear Mr Ban Ki-moon.
    Lancet. 2016;387:2352.
    PubMed     Text format    


  98. AMERATUNGA S, Denny S
    GBD 2013: a window into the world of young people.
    Lancet. 2016;387:2353-4.
    PubMed     Text format    


  99. PATTON GC, Sawyer SM, Santelli JS, Ross DA, et al
    Our future: a Lancet commission on adolescent health and wellbeing.
    Lancet. 2016;387:2423-78.
    PubMed     Text format    


  100. KLEINERT S, Horton R
    Adolescent health and wellbeing: a key to a sustainable future.
    Lancet. 2016;387:2355-6.
    PubMed     Text format    


  101. MCGILL F, Heyderman RS, Panagiotou S, Tunkel AR, et al
    Acute bacterial meningitis in adults.
    Lancet. 2016 Jun 2. pii: S0140-6736(16)30654.
    PubMed     Text format     Abstract available


    May 2016
  102. CHAN M
    Yellow fever: the resurgence of a forgotten disease.
    Lancet. 2016;387:2165-6.
    PubMed     Text format    


  103. DELFRAISSY JF, Yazdanpanah Y, Levy Y
    REACTing: the French response to infectious disease crises.
    Lancet. 2016;387:2183-5.
    PubMed     Text format    


  104. WATTS G
    Thomas Herald Rea.
    Lancet. 2016;387:2086.
    PubMed     Text format    


  105. MOKDAD AH, Forouzanfar MH, Daoud F, Mokdad AA, et al
    Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Lancet. 2016 May 9. pii: S0140-6736(16)00648.
    PubMed     Text format     Abstract available


  106. SHAH A, Keir M, Ducas R, Crean AM, et al
    Uric acid bladder stones in congenital cyanotic heart disease.
    Lancet. 2016 May 5. pii: S0140-6736(16)00347.
    PubMed     Text format    


    April 2016
  107. LEVY SD, Alladina JW, Hibbert KA, Harris RS, et al
    High-flow oxygen therapy and other inhaled therapies in intensive care units.
    Lancet. 2016;387:1867-78.
    PubMed     Text format     Abstract available


  108. GILBERT RE, Mok Q, Dwan K, Harron K, et al
    Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.
    Lancet. 2016;387:1732-42.
    PubMed     Text format     Abstract available


  109. RANDOLPH AG
    Pragmatic trials in critically ill children are CATCHing on.
    Lancet. 2016;387:1697-8.
    PubMed     Text format    


  110. NIELSEN KK, Bygbjerg IC
    Zika virus and hyperglycaemia in pregnancy.
    Lancet. 2016 Apr 18. pii: S0140-6736(16)30254.
    PubMed     Text format    


  111. LIEBERMAN A
    Recovery efforts in Flint slowly begin to take form.
    Lancet. 2016;387:1499-500.
    PubMed     Text format    


    February 2016
  112. WILLISON HJ, Jacobs BC, van Doorn PA
    Guillain-Barre syndrome.
    Lancet. 2016 Feb 29. pii: S0140-6736(16)00339.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: